Evaluation of cytomegalovirus quantification in blood by the R-gene® real-time PCR test;Évaluation de la quantification du cytomÉgalovirus dans le sang par le test de PCR en temps réel CMV R-gene®

Pathologie Biologie

Volumn 58, Issue 2, 2010, Pages 162-165

  Marque Juillet, S ^a   Touzard, A ^a   Monnier, S ^a   Fernand Laurent, C ^a   Therby, A ^a   Rigaudeau, S ^a   Harzic, M ^a  

^a CENTRE HOSPITALIER DE VERSAILLES   (France)

Author keywords

Antigenemia pp65; Cytomegalovirus; Quantitative PCR

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; VIRUS DNA; CYTOMEGALOVIRUS MATRIX PROTEIN 65KDA; MATRIX PROTEIN; PHOSPHOPROTEIN;

ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; DRUG EFFICACY; FEASIBILITY STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; NONHUMAN; PREDICTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VIRUS GENE; ANALYTICAL EQUIPMENT; BLOOD; BLOOD STORAGE; COMPARATIVE STUDY; COMPUTER SYSTEM; CRYOPRESERVATION; EARLY DIAGNOSIS; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; VIREMIA; VIROLOGY; VIRUS ACTIVATION; VIRUS LOAD;

BLOOD PRESERVATION; COMPUTER SYSTEMS; CRYOPRESERVATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; EARLY DIAGNOSIS; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD; VIRAL MATRIX PROTEINS; VIREMIA; VIRUS ACTIVATION;

EID: 77952091219     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2009.07.029     Document Type: Article

References (15)

1. Griffiths P.D., Emery V.C. Cytomegalovirus: clinical manifestations. Clinical Virology 2002, 445-447. ASM Press, Washington. D.D. Richman, R.J. Whitley, F.G. Hayden (Eds.).
2. de la Hoz R.E., Stephens G., Sherlock C. Diagnosis and treatment approaches to CMV infections in adult patients. J Clin Virol 2002, 25:S1-S12.
3. Baldanti F., Revello M.G., Percivalle E., Gerna G. Use of the human cytomegalovirus (HCMV) antigenemia assay for diagnosis and monitoring of HCMV infections and detection of antiviral drug resistance in the immunocompromised. J Clin Virol 1998, 11:51-60.
4. Singh Nina Cytomegalovirus infection in solid organ transplant recipients: New challenges and their implications for preventive strategies. J ClinVirol 2006, 35:474-477.
5. Van der Bij W., Torensma R., Van Son W.J., Anema J., Schirm J., Tegzess A.M. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leukocytes. J Med Virol 1988, 25:179-188.
6. Boeckh M., Boivin G. Quantification of cytomegalovirus: methodologic aspects and clinical applications. Microbiol Rev 1998, 11:533-554.
7. Gerna G., Zavattoni M., Baldanti F., Sarasini A., Chezzi L., Grossi P., et al. Human cytomegalovirus (HCMV) leukoDNAemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection. Transplantation 1998, 65:1378-1385.
8. The T.H., Van der Berg A.P., Harmsen M.C., Van der Bij W., Van Son W.J. The cytomegalovirus antigenemia assay: a plea for standardization. Scand J Infect Dis Suppl 1995, 99:25-29.
9. Landry M.L., Ferguson D., Cohen S., Huber K., Wetherill P. Effect of delayed specimen processing on cytomegalovirus antigenemia test results. J Clin Microbiol 1995, 33:257-259.
10. Allice T., Enrietto M., Pittaluga F., Varetto S., Franchello A., Marchiaro G., et al. Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: Comparison with end-point PCR and pp65 antigen test. J Med Virol 2006, 78:915-922.
11. Deback C., Fillet A.M., Dhedin N., Barrou B., Varnous S., Najioullah F., et al. Monitoring of human cytomegalovirus infection in immunosuppressed patients using real-time PCR on whole blood. J Clin Virol 2007, 40:173-179.
12. Garrigue I., Boucher S., Couzi L., Caumonta A., Dromerc C., Neau-Cransac M., et al. Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients. J Clin Virol 2006, 36:72-75.
13. Gourlain K., Salmon D., Gault E., Leport C., Katlama C., Matheron S., et al. Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapy. J Med Virol 2003, 69:401-407.
14. Sanghavi S.K., Abu-Elmagd K., Keightley M.C., St.George K., Lewandowski K., Boes S., et al. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients. J Clin Virol 2008, 42:335-342.
15. Gouarin S., Vabret A., Scieux C., Agbalika F., Cherot J., Mengelle C., et al. Multicentric evaluation of a new commercial cytomegalovirus real-time PCR quantitation assay. J Virol Methods 2007, 146:147-154.